Gilead Sciences and International Medical Corps Partner to Deliver Lifesaving Health Services to Syrian Refugees

Gilead Sciences and International Medical Corps Partner to Deliver Lifesaving Health Services to Syrian Refugees

Gilead Sciences, Inc. (Nasdaq:GILD) and International Medical Corps are partnering to provide health care and other vital services to Syrians who were forced to flee their homes because of Syria’s civil war.

syrian-refugee

Source: International Medical Corps

“Gilead Sciences’ very generous support will make it possible for International Medical Corps to protect the health of Syrian families as well as the local communities hosting them,” said Nancy Aossey, President and CEO of International Medical Corps. “With the war in Syria grinding on with no end in sight, these families and communities need our help. Gilead Sciences’ generosity will help us continue to be wherever we are most needed and expand our efforts to reach more Syrian families with lifesaving medical care and other services.”

A donation of $500 000 was made to International Medical Corps to help programs designed to support Syrians around the Middle East. This donation will not only help International Medical Corp to provide the health care needed by Syrians refugees, but also train frontline and community health workers, deliver pharmaceuticals and other medical supplies, and run health education campaigns in refugee communities.

Gregg Alton, Gilead Executive Vice President Commercial and Access Operations ALA, Corporate and Medical Affairs said, “It is our hope that through this partnership the refugee community will be able to overcome the many political, social and geographic barriers they face in accessing care.”

International Medical Corp has been on the front lines of the Syrian crises since it began six years ago. The conflict has sparked the largest migrations in modern history and it is estimated that 11 million Syrians have fled from their homes because of the war.

To learn more, click here.

ShareFacebooktwittergoogle_pluspinterestFacebooktwittergoogle_pluspinterest
FollowFacebooktwitterFacebooktwitter